← SynDRA
TAPINAROF
SynDRA canonical compound SYN0008903 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | AHR | CSNK2A1 | CSNK2B | LCK |
|---|
| Mechanism of action | aryl hydrocarbon receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- AHR AGONIST
- Aryl hydrocarbon receptor agonist
Drug classes
- Aryl Hydrocarbon Receptor Agonist
- Aryl Hydrocarbon Receptor Agonists
- Dermatologic Agents
ATC classes
- D05A · ANTIPSORIATICS FOR TOPICAL USE
Cross-references
Synonyms
- VTAMA
- Vtama
- vtama
- GSK2894512
- DMVT-505
- WBI-1001
- Benvitimod
- GSK-2894512
- 3,5-dihydroxy-4-isopropyl-trans-stilbene
- WBI 1001
- 3,5-Dihydroxy-4-isopropylstilbene
- 3,5-DH4IS
- tapinarofum
- RefChem:57353
- DTXCID101527189
- MFCD13193203
- Tapinarof [USAN]
- UNII-84HW7D0V04
- (E)-Benvitimod
- Tapinarof (Standard)
- Vtama (TN)
- Benvitimod (Tapinarof)
- TAPINAROF [INN]
- Tapinarof (JAN/USAN)
- TAPINAROF [WHO-DD]
- SCHEMBL918343
- GTPL9686
- orb1302687
- orb3025055
- CHEBI:215747
- GLXC-20861
- EX-A4877
- BDBM50603566
- MSK163810
- s9700
- AKOS025296109
- HY-109044R
- TN10179
Reported adverse events
- Abdominal pain
- Application site reaction
- Asthma
- Dermatitis
- Ear infection
- Folliculitis
- Headache
- Influenza
- Lower respiratory tract infection
- Nasopharyngitis
- Pain
- Pain in extremity
Look up TAPINAROF in the interactive SynDRA portal →